APO Research
Talk to an analyst

APO RESEARCH · REPORT

FAP Inhibitor

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global FAP Inhibitor Market Analysis and Forecast 2026-2032

29 December 2025197 pages

Choose your research edition.

Industry ResearchFAP Inhibitor Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal FAP Inhibitor Industry Growth and Trends Forecast to 203294 pages · $3,450 USDMarket StructureGlobal FAP Inhibitor Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032188 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal FAP Inhibitor Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal FAP Inhibitor Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global FAP Inhibitor market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for FAP Inhibitor is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for FAP Inhibitor is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for FAP Inhibitor is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for FAP Inhibitor is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of FAP Inhibitor include SOFIE, Ferronova, GE HealthCare, Isotopia, Lantheus, Bayer and Novartis AG, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for FAP Inhibitor, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of FAP Inhibitor, also provides the sales of main regions and countries. Of the upcoming market potential for FAP Inhibitor, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the FAP Inhibitor sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global FAP Inhibitor market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for FAP Inhibitor sales, projected growth trends, production technology, application and end-user industry.

FAP Inhibitor Segment by Company

SOFIE

Ferronova

GE HealthCare

Isotopia

Lantheus

Bayer

Novartis AG

FAP Inhibitor Segment by Type

Ga-labeled

F-labeled

Other

FAP Inhibitor Segment by Application

Tumor Diagnosis

Tumor Treatment

Others

FAP Inhibitor Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global FAP Inhibitor market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of FAP Inhibitor and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of FAP Inhibitor.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of FAP Inhibitor in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of FAP Inhibitor manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, FAP Inhibitor sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global FAP Inhibitor Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Ga-labeled Major Manufacturers Table 3. F-labeled Major Manufacturers Table 4. Other Major Manufacturers Table 5. Global FAP Inhibitor Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Tumor Diagnosis Major Manufacturers Table 7. Tumor Treatment Major Manufacturers Table 8. Others Major Manufacturers Table 9. FAP Inhibitor Industry Trends Table 10. FAP Inhibitor Industry Drivers Table 11. FAP Inhibitor Industry Opportunities and Challenges Table 12. FAP Inhibitor Industry Restraints Table 13. Global FAP Inhibitor Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 14. Global FAP Inhibitor Revenue by Region (2021-2026) & (US$ Million) Table 15. Global FAP Inhibitor Revenue by Region (2027-2032) & (US$ Million) Table 16. Global FAP Inhibitor Revenue Market Share by Region (2021-2026) Table 17. Global FAP Inhibitor Revenue Market Share by Region (2027-2032) Table 18. Global FAP Inhibitor Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 19. Global FAP Inhibitor Sales by Region (2021-2026) & (K Units) Table 20. Global FAP Inhibitor Sales by Region (2027-2032) & (K Units) Table 21. Global FAP Inhibitor Sales Market Share by Region (2021-2026) Table 22. Global FAP Inhibitor Sales Market Share by Region (2027-2032) Table 23. Global FAP Inhibitor Revenue by Manufacturers (US$ Million) & (2021-2026) Table 24. Global FAP Inhibitor Revenue Market Share by Manufacturers (2021-2026) Table 25. Global FAP Inhibitor Sales by Manufacturers (US$ Million) & (2021-2026) Table 26. Global FAP Inhibitor Sales Market Share by Manufacturers (2021-2026) Table 27. Global FAP Inhibitor Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 28. Global FAP Inhibitor Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 29. Global FAP Inhibitor Key Manufacturers Manufacturing Sites & Headquarters Table 30. Global FAP Inhibitor Manufacturers, Product Type & Application Table 31. Global FAP Inhibitor Manufacturers' Establishment Date Table 32. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global FAP Inhibitor by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 34. Global FAP Inhibitor Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global FAP Inhibitor Revenue by Type (2021-2026) & (US$ Million) Table 36. Global FAP Inhibitor Revenue by Type (2027-2032) & (US$ Million) Table 37. Global FAP Inhibitor Revenue Market Share by Type (2021-2026) Table 38. Global FAP Inhibitor Revenue Market Share by Type (2027-2032) Table 39. Global FAP Inhibitor Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 40. Global FAP Inhibitor Sales by Type (2021-2026) & (K Units) Table 41. Global FAP Inhibitor Sales by Type (2027-2032) & (K Units) Table 42. Global FAP Inhibitor Sales Market Share by Type (2021-2026) Table 43. Global FAP Inhibitor Sales Market Share by Type (2027-2032) Table 44. Global FAP Inhibitor Price by Type (2021-2026) & (US$/Unit) Table 45. Global FAP Inhibitor Price by Type (2027-2032) & (US$/Unit) Table 46. Global FAP Inhibitor Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global FAP Inhibitor Revenue by Application (2021-2026) & (US$ Million) Table 48. Global FAP Inhibitor Revenue by Application (2027-2032) & (US$ Million) Table 49. Global FAP Inhibitor Revenue Market Share by Application (2021-2026) Table 50. Global FAP Inhibitor Revenue Market Share by Application (2027-2032) Table 51. Global FAP Inhibitor Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 52. Global FAP Inhibitor Sales by Application (2021-2026) & (K Units) Table 53. Global FAP Inhibitor Sales by Application (2027-2032) & (K Units) Table 54. Global FAP Inhibitor Sales Market Share by Application (2021-2026) Table 55. Global FAP Inhibitor Sales Market Share by Application (2027-2032) Table 56. Global FAP Inhibitor Price by Application (2021-2026) & (US$/Unit) Table 57. Global FAP Inhibitor Price by Application (2027-2032) & (US$/Unit) Table 58. SOFIE Company Information Table 59. SOFIE Business Overview Table 60. SOFIE FAP Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. SOFIE FAP Inhibitor Product Portfolio Table 62. SOFIE Recent Development Table 63. Ferronova Company Information Table 64. Ferronova Business Overview Table 65. Ferronova FAP Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Ferronova FAP Inhibitor Product Portfolio Table 67. Ferronova Recent Development Table 68. GE HealthCare Company Information Table 69. GE HealthCare Business Overview Table 70. GE HealthCare FAP Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. GE HealthCare FAP Inhibitor Product Portfolio Table 72. GE HealthCare Recent Development Table 73. Isotopia Company Information Table 74. Isotopia Business Overview Table 75. Isotopia FAP Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Isotopia FAP Inhibitor Product Portfolio Table 77. Isotopia Recent Development Table 78. Lantheus Company Information Table 79. Lantheus Business Overview Table 80. Lantheus FAP Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Lantheus FAP Inhibitor Product Portfolio Table 82. Lantheus Recent Development Table 83. Bayer Company Information Table 84. Bayer Business Overview Table 85. Bayer FAP Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Bayer FAP Inhibitor Product Portfolio Table 87. Bayer Recent Development Table 88. Novartis AG Company Information Table 89. Novartis AG Business Overview Table 90. Novartis AG FAP Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Novartis AG FAP Inhibitor Product Portfolio Table 92. Novartis AG Recent Development Table 93. North America FAP Inhibitor Revenue by Type (2021-2026) & (US$ Million) Table 94. North America FAP Inhibitor Revenue by Type (2027-2032) & (US$ Million) Table 95. North America FAP Inhibitor Sales by Type (2021-2026) & (K Units) Table 96. North America FAP Inhibitor Sales by Type (2027-2032) & (K Units) Table 97. North America FAP Inhibitor Sales Price by Type (2021-2026) & (US$/Unit) Table 98. North America FAP Inhibitor Sales Price by Type (2027-2032) & (US$/Unit) Table 99. North America FAP Inhibitor Revenue by Application (2021-2026) & (US$ Million) Table 100. North America FAP Inhibitor Revenue by Application (2027-2032) & (US$ Million) Table 101. North America FAP Inhibitor Sales by Application (2021-2026) & (K Units) Table 102. North America FAP Inhibitor Sales by Application (2027-2032) & (K Units) Table 103. North America FAP Inhibitor Sales Price by Application (2021-2026) & (US$/Unit) Table 104. North America FAP Inhibitor Sales Price by Application (2027-2032) & (US$/Unit) Table 105. North America FAP Inhibitor Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 106. North America FAP Inhibitor Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 107. North America FAP Inhibitor Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 108. North America FAP Inhibitor Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 109. North America FAP Inhibitor Sales by Country (2021-2026) & (K Units) Table 110. North America FAP Inhibitor Sales by Country (2027-2032) & (K Units) Table 111. North America FAP Inhibitor Sales Price by Country (2021-2026) & (US$/Unit) Table 112. North America FAP Inhibitor Sales Price by Country (2027-2032) & (US$/Unit) Table 113. United States FAP Inhibitor Revenue (2021-2032) & (US$ Million) Table 114. Canada FAP Inhibitor Revenue (2021-2032) & (US$ Million) Table 115. Mexico FAP Inhibitor Revenue (2021-2032) & (US$ Million) Table 116. Europe FAP Inhibitor Revenue by Type (2021-2026) & (US$ Million) Table 117. Europe FAP Inhibitor Revenue by Type (2027-2032) & (US$ Million) Table 118. Europe FAP Inhibitor Sales by Type (2021-2026) & (K Units) Table 119. Europe FAP Inhibitor Sales by Type (2027-2032) & (K Units) Table 120. Europe FAP Inhibitor Sales Price by Type (2021-2026) & (US$/Unit) Table 121. Europe FAP Inhibitor Sales Price by Type (2027-2032) & (US$/Unit) Table 122. Europe FAP Inhibitor Revenue by Application (2021-2026) & (US$ Million) Table 123. Europe FAP Inhibitor Revenue by Application (2027-2032) & (US$ Million) Table 124. Europe FAP Inhibitor Sales by Application (2021-2026) & (K Units) Table 125. Europe FAP Inhibitor Sales by Application (2027-2032) & (K Units) Table 126. Europe FAP Inhibitor Sales Price by Application (2021-2026) & (US$/Unit) Table 127. Europe FAP Inhibitor Sales Price by Application (2027-2032) & (US$/Unit) Table 128. Europe FAP Inhibitor Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 129. Europe FAP Inhibitor Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 130. Europe FAP Inhibitor Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 131. Europe FAP Inhibitor Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 132. Europe FAP Inhibitor Sales by Country (2021-2026) & (K Units) Table 133. Europe FAP Inhibitor Sales by Country (2027-2032) & (K Units) Table 134. Europe FAP Inhibitor Sales Price by Country (2021-2026) & (US$/Unit) Table 135. Europe FAP Inhibitor Sales Price by Country (2027-2032) & (US$/Unit) Table 136. Germany FAP Inhibitor Revenue (2021-2032) & (US$ Million) Table 137. France FAP Inhibitor Revenue (2021-2032) & (US$ Million) Table 138. U.K. FAP Inhibitor Revenue (2021-2032) & (US$ Million) Table 139. Italy FAP Inhibitor Revenue (2021-2032) & (US$ Million) Table 140. Russia FAP Inhibitor Revenue (2021-2032) & (US$ Million) Table 141. Spain FAP Inhibitor Revenue (2021-2032) & (US$ Million) Table 142. Netherlands FAP Inhibitor Revenue (2021-2032) & (US$ Million) Table 143. Switzerland FAP Inhibitor Revenue (2021-2032) & (US$ Million) Table 144. Sweden FAP Inhibitor Revenue (2021-2032) & (US$ Million) Table 145. Poland FAP Inhibitor Revenue (2021-2032) & (US$ Million) Table 146. China FAP Inhibitor Revenue by Type (2021-2026) & (US$ Million) Table 147. China FAP Inhibitor Revenue by Type (2027-2032) & (US$ Million) Table 148. China FAP Inhibitor Sales by Type (2021-2026) & (K Units) Table 149. China FAP Inhibitor Sales by Type (2027-2032) & (K Units) Table 150. China FAP Inhibitor Sales Price by Type (2021-2026) & (US$/Unit) Table 151. China FAP Inhibitor Sales Price by Type (2027-2032) & (US$/Unit) Table 152. China FAP Inhibitor Revenue by Application (2021-2026) & (US$ Million) Table 153. China FAP Inhibitor Revenue by Application (2027-2032) & (US$ Million) Table 154. China FAP Inhibitor Sales by Application (2021-2026) & (K Units) Table 155. China FAP Inhibitor Sales by Application (2027-2032) & (K Units) Table 156. China FAP Inhibitor Sales Price by Application (2021-2026) & (US$/Unit) Table 157. China FAP Inhibitor Sales Price by Application (2027-2032) & (US$/Unit) Table 158. Asia FAP Inhibitor Revenue by Type (2021-2026) & (US$ Million) Table 159. Asia FAP Inhibitor Revenue by Type (2027-2032) & (US$ Million) Table 160. Asia FAP Inhibitor Sales by Type (2021-2026) & (K Units) Table 161. Asia FAP Inhibitor Sales by Type (2027-2032) & (K Units) Table 162. Asia FAP Inhibitor Sales Price by Type (2021-2026) & (US$/Unit) Table 163. Asia FAP Inhibitor Sales Price by Type (2027-2032) & (US$/Unit) Table 164. Asia FAP Inhibitor Revenue by Application (2021-2026) & (US$ Million) Table 165. Asia FAP Inhibitor Revenue by Application (2027-2032) & (US$ Million) Table 166. Asia FAP Inhibitor Sales by Application (2021-2026) & (K Units) Table 167. Asia FAP Inhibitor Sales by Application (2027-2032) & (K Units) Table 168. Asia FAP Inhibitor Sales Price by Application (2021-2026) & (US$/Unit) Table 169. Asia FAP Inhibitor Sales Price by Application (2027-2032) & (US$/Unit) Table 170. Asia FAP Inhibitor Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 171. Asia FAP Inhibitor Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 172. Asia FAP Inhibitor Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 173. Asia FAP Inhibitor Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 174. Asia FAP Inhibitor Sales by Country (2021-2026) & (K Units) Table 175. Asia FAP Inhibitor Sales by Country (2027-2032) & (K Units) Table 176. Asia FAP Inhibitor Sales Price by Country (2021-2026) & (US$/Unit) Table 177. Asia FAP Inhibitor Sales Price by Country (2027-2032) & (US$/Unit) Table 178. Japan FAP Inhibitor Revenue (2021-2032) & (US$ Million) Table 179. South Korea FAP Inhibitor Revenue (2021-2032) & (US$ Million) Table 180. India FAP Inhibitor Revenue (2021-2032) & (US$ Million) Table 181. Australia FAP Inhibitor Revenue (2021-2032) & (US$ Million) Table 182. Taiwan FAP Inhibitor Revenue (2021-2032) & (US$ Million) Table 183. Southeast Asia FAP Inhibitor Revenue (2021-2032) & (US$ Million) Table 184. SAMEA FAP Inhibitor Revenue by Type (2021-2026) & (US$ Million) Table 185. SAMEA FAP Inhibitor Revenue by Type (2027-2032) & (US$ Million) Table 186. SAMEA FAP Inhibitor Sales by Type (2021-2026) & (K Units) Table 187. SAMEA FAP Inhibitor Sales by Type (2027-2032) & (K Units) Table 188. SAMEA FAP Inhibitor Sales Price by Type (2021-2026) & (US$/Unit) Table 189. SAMEA FAP Inhibitor Sales Price by Type (2027-2032) & (US$/Unit) Table 190. SAMEA FAP Inhibitor Revenue by Application (2021-2026) & (US$ Million) Table 191. SAMEA FAP Inhibitor Revenue by Application (2027-2032) & (US$ Million) Table 192. SAMEA FAP Inhibitor Sales by Application (2021-2026) & (K Units) Table 193. SAMEA FAP Inhibitor Sales by Application (2027-2032) & (K Units) Table 194. SAMEA FAP Inhibitor Sales Price by Application (2021-2026) & (US$/Unit) Table 195. SAMEA FAP Inhibitor Sales Price by Application (2027-2032) & (US$/Unit) Table 196. SAMEA FAP Inhibitor Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 197. SAMEA FAP Inhibitor Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 198. SAMEA FAP Inhibitor Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 199. SAMEA FAP Inhibitor Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 200. SAMEA FAP Inhibitor Sales by Country (2021-2026) & (K Units) Table 201. SAMEA FAP Inhibitor Sales by Country (2027-2032) & (K Units) Table 202. SAMEA FAP Inhibitor Sales Price by Country (2021-2026) & (US$/Unit) Table 203. SAMEA FAP Inhibitor Sales Price by Country (2027-2032) & (US$/Unit) Table 204. Brazil FAP Inhibitor Revenue (2021-2032) & (US$ Million) Table 205. Argentina FAP Inhibitor Revenue (2021-2032) & (US$ Million) Table 206. Chile FAP Inhibitor Revenue (2021-2032) & (US$ Million) Table 207. Colombia FAP Inhibitor Revenue (2021-2032) & (US$ Million) Table 208. Peru FAP Inhibitor Revenue (2021-2032) & (US$ Million) Table 209. Saudi Arabia FAP Inhibitor Revenue (2021-2032) & (US$ Million) Table 210. Israel FAP Inhibitor Revenue (2021-2032) & (US$ Million) Table 211. UAE FAP Inhibitor Revenue (2021-2032) & (US$ Million) Table 212. Turkey FAP Inhibitor Revenue (2021-2032) & (US$ Million) Table 213. Iran FAP Inhibitor Revenue (2021-2032) & (US$ Million) Table 214. Egypt FAP Inhibitor Revenue (2021-2032) & (US$ Million) Table 215. Key Raw Materials Table 216. Raw Materials Key Suppliers Table 217. FAP Inhibitor Distributors List Table 218. FAP Inhibitor Customers List Table 219. Research Programs/Design for This Report Table 220. Authors List of This Report Table 221. Secondary Sources Table 222. Primary Sources List of Figures Figure 1. FAP Inhibitor Image Figure 2. Global FAP Inhibitor Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global FAP Inhibitor Market Size Share 2021 VS 2025 VS 2032 Figure 4. Ga-labeled Image Figure 5. F-labeled Image Figure 6. Other Image Figure 7. Global FAP Inhibitor Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global FAP Inhibitor Market Size Share 2021 VS 2025 VS 2032 Figure 9. Tumor Diagnosis Image Figure 10. Tumor Treatment Image Figure 11. Others Image Figure 12. Global FAP Inhibitor Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global FAP Inhibitor Revenue (2021-2032) & (US$ Million) Figure 14. Global FAP Inhibitor Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 15. Global FAP Inhibitor Revenue Market Share by Region: 2025 Versus 2032 Figure 16. Global FAP Inhibitor Revenue Market Share by Region (2021-2032) Figure 17. Global FAP Inhibitor Sales (2021-2032) & (K Units) Figure 18. Global FAP Inhibitor Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 19. Global FAP Inhibitor Sales Market Share by Region (2021-2032) Figure 20. US & Canada & Mexico FAP Inhibitor Sales YoY (2021-2032) & (K Units) Figure 21. Europe FAP Inhibitor Sales YoY (2021-2032) & (K Units) Figure 22. China FAP Inhibitor Sales YoY (2021-2032) & (K Units) Figure 23. Asia (Excluding China) FAP Inhibitor Sales YoY (2021-2032) & (K Units) Figure 24. South America, Middle East and Africa FAP Inhibitor Sales YoY (2021-2032) & (K Units) Figure 25. Global FAP Inhibitor Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 26. Global FAP Inhibitor Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 27. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 28. Global FAP Inhibitor Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global FAP Inhibitor Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 30. Global FAP Inhibitor Revenue Market Share by Type (2021-2032) Figure 31. Global FAP Inhibitor Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 32. Global FAP Inhibitor Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global FAP Inhibitor Sales Market Share by Type (2021-2032) Figure 34. Global FAP Inhibitor Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global FAP Inhibitor Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 36. Global FAP Inhibitor Revenue Market Share by Application (2021-2032) Figure 37. Global FAP Inhibitor Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 38. Global FAP Inhibitor Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global FAP Inhibitor Sales Market Share by Application (2021-2032) Figure 40. North America FAP Inhibitor Revenue Share by Type (2021-2032) Figure 41. North America FAP Inhibitor Sales Share by Type (2021-2032) Figure 42. North America FAP Inhibitor Revenue Share by Application (2021-2032) Figure 43. North America FAP Inhibitor Sales Share by Application (2021-2032) Figure 44. North America FAP Inhibitor Revenue Share by Country (2021-2032) Figure 45. North America FAP Inhibitor Sales Share by Country (2021-2032) Figure 46. Europe FAP Inhibitor Revenue Share by Type (2021-2032) Figure 47. Europe FAP Inhibitor Sales Share by Type (2021-2032) Figure 48. Europe FAP Inhibitor Revenue Share by Application (2021-2032) Figure 49. Europe FAP Inhibitor Sales Share by Application (2021-2032) Figure 50. Europe FAP Inhibitor Revenue Share by Country (2021-2032) Figure 51. Europe FAP Inhibitor Sales Share by Country (2021-2032) Figure 52. China FAP Inhibitor Revenue Share by Type (2021-2032) Figure 53. China FAP Inhibitor Sales Share by Type (2021-2032) Figure 54. China FAP Inhibitor Revenue Share by Application (2021-2032) Figure 55. China FAP Inhibitor Sales Share by Application (2021-2032) Figure 56. Asia FAP Inhibitor Revenue Share by Type (2021-2032) Figure 57. Asia FAP Inhibitor Sales Share by Type (2021-2032) Figure 58. Asia FAP Inhibitor Revenue Share by Application (2021-2032) Figure 59. Asia FAP Inhibitor Sales Share by Application (2021-2032) Figure 60. Asia FAP Inhibitor Revenue Share by Country (2021-2032) Figure 61. Asia FAP Inhibitor Sales Share by Country (2021-2032) Figure 62. SAMEA FAP Inhibitor Revenue Share by Type (2021-2032) Figure 63. SAMEA FAP Inhibitor Sales Share by Type (2021-2032) Figure 64. SAMEA FAP Inhibitor Revenue Share by Application (2021-2032) Figure 65. SAMEA FAP Inhibitor Sales Share by Application (2021-2032) Figure 66. SAMEA FAP Inhibitor Revenue Share by Country (2021-2032) Figure 67. SAMEA FAP Inhibitor Sales Share by Country (2021-2032) Figure 68. FAP Inhibitor Value Chain Figure 69. Manufacturing Cost Structure Figure 70. FAP Inhibitor Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Ga-labeled
  • F-labeled
  • Other
Applications
  • Tumor Diagnosis
  • Tumor Treatment
  • Others
Companies covered
  • SOFIE
  • Ferronova
  • GE HealthCare
  • Isotopia
  • Lantheus
  • Bayer
  • Novartis AG

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 FAP Inhibitor Market by Type
  3. 1.2.1 Global FAP Inhibitor Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Ga-labeled
  5. 1.2.3 F-labeled
  6. 1.2.4 Other
  7. 1.3 FAP Inhibitor Market by Application
  8. 1.3.1 Global FAP Inhibitor Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Tumor Diagnosis
  10. 1.3.3 Tumor Treatment
  11. 1.3.4 Others
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 FAP Inhibitor Market Dynamics
  1. 2.1 FAP Inhibitor Industry Trends
  2. 2.2 FAP Inhibitor Industry Drivers
  3. 2.3 FAP Inhibitor Industry Opportunities and Challenges
  4. 2.4 FAP Inhibitor Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global FAP Inhibitor Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global FAP Inhibitor Revenue by Region
  3. 3.2.1 Global FAP Inhibitor Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global FAP Inhibitor Revenue by Region (2021-2026)
  5. 3.2.3 Global FAP Inhibitor Revenue by Region (2027-2032)
  6. 3.2.4 Global FAP Inhibitor Revenue Market Share by Region (2021-2032)
  7. 3.3 Global FAP Inhibitor Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global FAP Inhibitor Sales by Region
  9. 3.4.1 Global FAP Inhibitor Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global FAP Inhibitor Sales by Region (2021-2026)
  11. 3.4.3 Global FAP Inhibitor Sales by Region (2027-2032)
  12. 3.4.4 Global FAP Inhibitor Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global FAP Inhibitor Revenue by Manufacturers
  2. 4.1.1 Global FAP Inhibitor Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global FAP Inhibitor Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global FAP Inhibitor Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global FAP Inhibitor Sales by Manufacturers
  6. 4.2.1 Global FAP Inhibitor Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global FAP Inhibitor Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global FAP Inhibitor Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global FAP Inhibitor Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global FAP Inhibitor Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global FAP Inhibitor Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global FAP Inhibitor Manufacturers, Product Type & Application
  13. 4.7 Global FAP Inhibitor Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global FAP Inhibitor Market CR5 and HHI
  16. 4.8.2 2025 FAP Inhibitor Tier 1, Tier 2, and Tier 3
5 FAP Inhibitor Market by Type
  1. 5.1 Global FAP Inhibitor Revenue by Type
  2. 5.1.1 Global FAP Inhibitor Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global FAP Inhibitor Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global FAP Inhibitor Revenue Market Share by Type (2021-2032)
  5. 5.2 Global FAP Inhibitor Sales by Type
  6. 5.2.1 Global FAP Inhibitor Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global FAP Inhibitor Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global FAP Inhibitor Sales Market Share by Type (2021-2032)
  9. 5.3 Global FAP Inhibitor Price by Type
6 FAP Inhibitor Market by Application
  1. 6.1 Global FAP Inhibitor Revenue by Application
  2. 6.1.1 Global FAP Inhibitor Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global FAP Inhibitor Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global FAP Inhibitor Revenue Market Share by Application (2021-2032)
  5. 6.2 Global FAP Inhibitor Sales by Application
  6. 6.2.1 Global FAP Inhibitor Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global FAP Inhibitor Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global FAP Inhibitor Sales Market Share by Application (2021-2032)
  9. 6.3 Global FAP Inhibitor Price by Application
7 Company Profiles
  1. 7.1 SOFIE
  2. 7.1.1 SOFIE Company Information
  3. 7.1.2 SOFIE Business Overview
  4. 7.1.3 SOFIE FAP Inhibitor Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 SOFIE FAP Inhibitor Product Portfolio
  6. 7.1.5 SOFIE Recent Developments
  7. 7.2 Ferronova
  8. 7.2.1 Ferronova Company Information
  9. 7.2.2 Ferronova Business Overview
  10. 7.2.3 Ferronova FAP Inhibitor Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Ferronova FAP Inhibitor Product Portfolio
  12. 7.2.5 Ferronova Recent Developments
  13. 7.3 GE HealthCare
  14. 7.3.1 GE HealthCare Company Information
  15. 7.3.2 GE HealthCare Business Overview
  16. 7.3.3 GE HealthCare FAP Inhibitor Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 GE HealthCare FAP Inhibitor Product Portfolio
  18. 7.3.5 GE HealthCare Recent Developments
  19. 7.4 Isotopia
  20. 7.4.1 Isotopia Company Information
  21. 7.4.2 Isotopia Business Overview
  22. 7.4.3 Isotopia FAP Inhibitor Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Isotopia FAP Inhibitor Product Portfolio
  24. 7.4.5 Isotopia Recent Developments
  25. 7.5 Lantheus
  26. 7.5.1 Lantheus Company Information
  27. 7.5.2 Lantheus Business Overview
  28. 7.5.3 Lantheus FAP Inhibitor Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Lantheus FAP Inhibitor Product Portfolio
  30. 7.5.5 Lantheus Recent Developments
  31. 7.6 Bayer
  32. 7.6.1 Bayer Company Information
  33. 7.6.2 Bayer Business Overview
  34. 7.6.3 Bayer FAP Inhibitor Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Bayer FAP Inhibitor Product Portfolio
  36. 7.6.5 Bayer Recent Developments
  37. 7.7 Novartis AG
  38. 7.7.1 Novartis AG Company Information
  39. 7.7.2 Novartis AG Business Overview
  40. 7.7.3 Novartis AG FAP Inhibitor Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Novartis AG FAP Inhibitor Product Portfolio
  42. 7.7.5 Novartis AG Recent Developments
8 North America
  1. 8.1 North America FAP Inhibitor Market Size by Type
  2. 8.1.1 North America FAP Inhibitor Revenue by Type (2021-2032)
  3. 8.1.2 North America FAP Inhibitor Sales by Type (2021-2032)
  4. 8.1.3 North America FAP Inhibitor Price by Type (2021-2032)
  5. 8.2 North America FAP Inhibitor Market Size by Application
  6. 8.2.1 North America FAP Inhibitor Revenue by Application (2021-2032)
  7. 8.2.2 North America FAP Inhibitor Sales by Application (2021-2032)
  8. 8.2.3 North America FAP Inhibitor Price by Application (2021-2032)
  9. 8.3 North America FAP Inhibitor Market Size by Country
  10. 8.3.1 North America FAP Inhibitor Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America FAP Inhibitor Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America FAP Inhibitor Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe FAP Inhibitor Market Size by Type
  2. 9.1.1 Europe FAP Inhibitor Revenue by Type (2021-2032)
  3. 9.1.2 Europe FAP Inhibitor Sales by Type (2021-2032)
  4. 9.1.3 Europe FAP Inhibitor Price by Type (2021-2032)
  5. 9.2 Europe FAP Inhibitor Market Size by Application
  6. 9.2.1 Europe FAP Inhibitor Revenue by Application (2021-2032)
  7. 9.2.2 Europe FAP Inhibitor Sales by Application (2021-2032)
  8. 9.2.3 Europe FAP Inhibitor Price by Application (2021-2032)
  9. 9.3 Europe FAP Inhibitor Market Size by Country
  10. 9.3.1 Europe FAP Inhibitor Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe FAP Inhibitor Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe FAP Inhibitor Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China FAP Inhibitor Market Size by Type
  2. 10.1.1 China FAP Inhibitor Revenue by Type (2021-2032)
  3. 10.1.2 China FAP Inhibitor Sales by Type (2021-2032)
  4. 10.1.3 China FAP Inhibitor Price by Type (2021-2032)
  5. 10.2 China FAP Inhibitor Market Size by Application
  6. 10.2.1 China FAP Inhibitor Revenue by Application (2021-2032)
  7. 10.2.2 China FAP Inhibitor Sales by Application (2021-2032)
  8. 10.2.3 China FAP Inhibitor Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia FAP Inhibitor Market Size by Type
  2. 11.1.1 Asia FAP Inhibitor Revenue by Type (2021-2032)
  3. 11.1.2 Asia FAP Inhibitor Sales by Type (2021-2032)
  4. 11.1.3 Asia FAP Inhibitor Price by Type (2021-2032)
  5. 11.2 Asia FAP Inhibitor Market Size by Application
  6. 11.2.1 Asia FAP Inhibitor Revenue by Application (2021-2032)
  7. 11.2.2 Asia FAP Inhibitor Sales by Application (2021-2032)
  8. 11.2.3 Asia FAP Inhibitor Price by Application (2021-2032)
  9. 11.3 Asia FAP Inhibitor Market Size by Country
  10. 11.3.1 Asia FAP Inhibitor Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia FAP Inhibitor Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia FAP Inhibitor Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA FAP Inhibitor Market Size by Type
  2. 12.1.1 SAMEA FAP Inhibitor Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA FAP Inhibitor Sales by Type (2021-2032)
  4. 12.1.3 SAMEA FAP Inhibitor Price by Type (2021-2032)
  5. 12.2 SAMEA FAP Inhibitor Market Size by Application
  6. 12.2.1 SAMEA FAP Inhibitor Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA FAP Inhibitor Sales by Application (2021-2032)
  8. 12.2.3 SAMEA FAP Inhibitor Price by Application (2021-2032)
  9. 12.3 SAMEA FAP Inhibitor Market Size by Country
  10. 12.3.1 SAMEA FAP Inhibitor Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA FAP Inhibitor Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA FAP Inhibitor Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 FAP Inhibitor Value Chain Analysis
  2. 13.1.1 FAP Inhibitor Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 FAP Inhibitor Production Mode & Process
  6. 13.2 FAP Inhibitor Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 FAP Inhibitor Distributors
  9. 13.2.3 FAP Inhibitor Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst